Kitazato

Kitazato Accounts Payable

The Accounts Payable of Kitazato (368A.T) as of Nov 17, 2026 is 252.00 M JPY. In the previous year, Accounts Payable was 135.00 M JPY — a change of 86.67% (higher).

Accounts Payable

252.00 MJPY

YoY

86.67%

Last updated:

Accounts Payable of Kitazato is 2025 252.00 M JPY. Accounts Payable of Kitazato was 2024 135.00 M JPY. It decreases by 86.67% higher compared to the previous year.

The Kitazato Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2023
168.00 M JPY
Jan 1, 2024
135.00 M JPY
Jan 1, 2025
252.00 M JPY
The Kitazato Accounts Payable history
YEARAccounts PayableYoY
252.00 MJPY+86.67%
135.00 MJPY-19.64%
168.00 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Accounts Payable of Kitazato is 252.00 M JPY in 2025.

Accounts Payable of Kitazato changed from 135.00 M JPY to 252.00 M JPY, representing a 86.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Kitazato since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Kitazato historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Kitazato

All Key Metrics — Kitazato